Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism Nov. 30, 2021 No Comments
One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia Nov. 22, 2021 No Comments
New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome Nov. 4, 2021 No Comments
RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder Nov. 2, 2021 No Comments
Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury Oct. 8, 2021 No Comments